<DOC>
	<DOCNO>NCT01660542</DOCNO>
	<brief_summary>This multicenter , open-label , phase IV trial ass efficacy safety sequential neoadjuvant chemotherapy 4 cycle doxorubicin/cyclophosphamide follow 4 cycle docetaxel ( Monotaxel® ) patient breast cancer ≥5cm size cytologically confirm axillary lymph node metastasis .</brief_summary>
	<brief_title>An Open-label , Multi-center Phase Ⅳ Trial Evaluate Efficacy Safety Sequential Neoadjuvant Chemotherapy With Docetaxel ( Monotaxel® ) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy Locally Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>1 . Patients histologically proven invasive breast cancer primary tumor size least 5cm cytologically proven axillary node metastasis 2. evidence systemic metastasis pathologically radiologically 3. age time diagnosis 20 70 year 4. patient previously untreated primary breast cancer include chemotherapy 5. general performance status ECOG 02 6. sufficient hematopoietic function ( absolute neutrophil count ≥ 1,500/mm3 , platelet count ≥ 100,000/mm3 , hemoglobin ≥ 10 g/dL ) 7. sufficient renal function ( serum creatinine level ≤ 1.5 mg/dL ) 8. sufficient liver function ( total serum bilirubin level ≤ 1.5 time upper normal limit ; serum AST ALT level ≤ 1.5 time upper normal limit ; serum alkaline phosphatase level ≤ 1.5 time upper normal limit ) 9. sufficient cardiac function ( normal electrocardiography within 1 month LVEF &gt; 50 % echocardiography MUGA scan within 3 month ) 10. patient agree enroll clinical trial sign write informed consent voluntarily 1. patient evidence distant metastasis 2. patient previous malignancy except breast cancer 3. pregnant ( positive hCG test 1 week registration ) lactate patient 4. uncontrolled serious infection 5. patient psychiatric disease epilepsy 6. patient clinically severe cardiac disease within 6 month atrial ventricular arrhythmia , congestive heart failure , myocardial infarction , unstable angina 7. male breast cancer 8. patient poor general condition able understand sign write informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>